Jw Pharmac (001060) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.075x

Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.075x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩27.55 Billion ≈ $18.67 Million USD) by net assets (₩369.37 Billion ≈ $250.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Jw Pharmac's balance sheet to measure how much of total assets are equity-financed.

Jw Pharmac - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jw Pharmac (001060) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Jw Pharmac Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hibiscus Petroleum BHD KLSE:5199	-0.186x
PetroVietnam Transportation Corp VN:PVT	0.057x
Shandong Minhe Animal Husbandry Co Ltd SHE:002234	0.026x
HCR Co Ltd SHG:688500	0.001x
Tande Co Ltd SHG:600665	0.096x
Aydem Yenilenebilir Enerji AS IS:AYDEM	-0.073x
Revenio Group Corporation HE:REG1V	-0.029x
Norske Skog Asa OL:NSKOG	-0.052x

Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2025)

The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Jw Pharmac (001060) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩369.37 Billion ≈ $250.32 Million	₩96.40 Billion ≈ $65.33 Million	0.261x	+8.31%
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-156.95%
2014-12-31	₩223.83 Billion ≈ $151.68 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	-65.14%
2013-12-31	₩200.74 Billion ≈ $136.04 Million	₩18.72 Billion ≈ $12.69 Million	0.093x	-76.23%
2012-12-31	₩163.66 Billion ≈ $110.91 Million	₩64.21 Billion ≈ $43.52 Million	0.392x	+1233.92%
2006-12-31	₩172.48 Billion ≈ $116.89 Million	₩5.07 Billion ≈ $3.44 Million	0.029x	-95.00%
2005-12-31	₩119.44 Billion ≈ $80.95 Million	₩70.25 Billion ≈ $47.61 Million	0.588x	+367.61%
2004-12-31	₩119.39 Billion ≈ $80.91 Million	₩15.02 Billion ≈ $10.18 Million	0.126x	-16.92%
2003-12-31	₩112.60 Billion ≈ $76.31 Million	₩17.05 Billion ≈ $11.55 Million	0.151x	-46.93%
2002-12-31	₩100.72 Billion ≈ $68.26 Million	₩28.74 Billion ≈ $19.47 Million	0.285x	-43.68%
2001-12-31	₩88.92 Billion ≈ $60.26 Million	₩45.04 Billion ≈ $30.52 Million	0.507x	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$359.11 Million

₩529.91 Billion KRW

Market Cap Rank

#13814 Global

#402 in Korea

Share Price

₩23500.00

Change (1 day)

+3.98%

52-Week Range

₩20950.00 - ₩39050.00

All Time High

₩75306.05